Stock Research for RDHL

RDHL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

RDHL Stock Chart & Research Data

The RDHL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RDHL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


RDHL Due diligence Resources & Stock Charts

The RDHL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View RDHL Detailed Price Forecast - CNN Money CNN View RDHL Detailed Summary - Google Finance
Yahoo View RDHL Detailed Summary - Yahoo! Finance Zacks View RDHL Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View RDHL Trends & Analysis - Trade-Ideas Barrons View RDHL Major Holders - Barrons
NASDAQ View RDHL Call Transcripts - NASDAQ Seeking View RDHL Breaking News & Analysis - Seeking Alpha
Spotlight View RDHL Annual Report - CompanySpotlight.com OTC Report View RDHL OTC Short Report - OTCShortReport.com
TradeKing View RDHL Fundamentals - TradeKing Charts View RDHL SEC Filings - Bar Chart
WSJ View Historical Prices for RDHL - The WSJ Morningstar View Performance/Total Return for RDHL - Morningstar
MarketWatch View the Analyst Estimates for RDHL - MarketWatch CNBC View the Earnings History for RDHL - CNBC
StockMarketWatch View the RDHL Earnings - StockMarketWatch MacroAxis View RDHL Buy or Sell Recommendations - MacroAxis
Bullish View the RDHL Bullish Patterns - American Bulls Short Pains View RDHL Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View RDHL Stock Mentions - StockTwits PennyStocks View RDHL Stock Mentions - PennyStockTweets
Twitter View RDHL Stock Mentions - Twitter Invest Hub View RDHL Investment Forum News - Investor Hub
Yahoo View RDHL Stock Mentions - Yahoo! Message Board Seeking Alpha View RDHL Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for RDHL - SECform4.com Insider Cow View Insider Transactions for RDHL - Insider Cow
CNBC View RDHL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for RDHL - OTC Markets
Yahoo View Insider Transactions for RDHL - Yahoo! Finance NASDAQ View Institutional Holdings for RDHL - NASDAQ


Stock Charts

FinViz View RDHL Stock Insight & Charts - FinViz.com StockCharts View RDHL Investment Charts - StockCharts.com
BarChart View RDHL Stock Overview & Charts - BarChart Trading View View RDHL User Generated Charts - Trading View




Latest Financial News for RDHL


RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
Posted on Wednesday April 24, 2024

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the first patient has been enrolled in the Austere environments Consortium for Enhanced Sepsis Outcomes' (ACESO) U.S. government-supported PROTECT multinational platform trial for early COVID-19 outpatient treatment. RHB-107 (upamostat) is the first drug being tested in this platform study. Funded through non-dilutive external sources, including the U.S. Department of D


RedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (vs US$46.29 loss in FY 2022)
Posted on Wednesday April 10, 2024

RedHill Biopharma ( NASDAQ:RDHL ) Full Year 2023 Results Key Financial Results Net income: US$23.9m (up from US$71.7m...


RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Posted on Monday April 08, 2024

RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its full year 2023 financial results and operational highlights and associated filing of its annual report on Form 20-F for the year ended December 31, 2023.


RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
Posted on Tuesday April 02, 2024

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into definitive agreements with private investors for the purchase and sale, at a premium, of 2,144,487 of the Company's American Depositary Shares ("ADSs"), each ADS representing four hundred (400) ordinary shares, par value NIS 0.01 per share, of the Company, and warrants to purchase up to an aggregate of 2,144,487ADSs, at a purchase price of $0.58289 p


Stock Market & Investing Books

Enter a stock symbol to view the stock details.